Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transplantation osteoporosis.

Emily Stein1, Peter Ebeling, Elizabeth Shane

  • 1Division of Endocrinology, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 West 168th Street, PH8-864, New York, NY 10032, USA.

Endocrinology and Metabolism Clinics of North America
|November 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postpartum timing of teriparatide initiation and BMD response in pregnancy- and lactation-associated osteoporosis: an observational study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Evaluating the performance of large language models in sarcopenia-related patient queries: a foundational assessment for patient-centered validation.

Frontiers in aging·2026
Same author

Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MS.

BMJ open sport & exercise medicine·2026
Same author

Effects of tibial fracture-induced gait alterations on healing outcomes: Implications for patient-specific rehabilitation strategies.

Computer methods and programs in biomedicine·2026
Same author

Weight loss therapies and osteoporosis risk - Authors' reply.

Lancet (London, England)·2026
Same author

Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Osteoporosis is common in transplant patients due to pre-existing conditions and immunosuppressive drugs. Bisphosphonates are effective in preventing and treating bone loss after transplantation.

Area of Science:

  • Nephrology
  • Immunology
  • Endocrinology

Background:

  • Osteoporosis is a significant complication in organ transplant recipients.
  • Pre-transplantation bone density can be affected by chronic illness, organ failure, and treatments.
  • Post-transplantation bone loss is frequently linked to immunosuppressive therapies.

Purpose of the Study:

  • To review the factors contributing to osteoporosis in transplant recipients.
  • To discuss the impact of immunosuppressive drugs on bone health.
  • To highlight effective management strategies for post-transplantation osteoporosis.

Main Methods:

  • Literature review of studies on osteoporosis in transplant recipients.
  • Analysis of the effects of immunosuppressive agents on bone metabolism.

Related Experiment Videos

  • Evaluation of treatment options for bone loss.

    • Main Results:

    • Both pre-existing conditions and post-transplant immunosuppression contribute to osteoporosis.
    • Glucocorticoids and calcineurin inhibitors adversely affect bone remodeling.
    • Newer immunosuppressants may allow for lower steroid doses, potentially reducing bone loss.

    Conclusions:

    • Osteoporosis management is crucial in transplant recipients.
    • Bisphosphonates are the primary agents for preventing and treating post-transplantation osteoporosis.
    • Careful selection of immunosuppressive regimens may mitigate bone loss.